STERIS plc (STE)
NYSE • Healthcare
Last close at October 2, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, STERIS plc keeps $13 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 4
in 31 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
STERIS plc’s adjusted EPS of $2.59 topped the $2.49 estimate by 4%, up about 11% from $2.34 a year ago, in the first fiscal quarter of 2027 based on preliminary results reported Aug. 5, 2026. Gross profit reached about $684.2 million, while operating cash flow was $367.1 million and the company paid $61.4 million in dividends.
About STERIS plc
STERIS plc is a healthcare equipment and services company listed on the NYSE as STE that focuses on infection prevention, sterilization, and procedure support for healthcare and life sciences customers. Across its medical-specialties niches, STERIS generated $5.9 billion of revenue in FY2026.
Today's Snapshot
STE ended the day slightly lower at 208.48, in line with a flat sector.
Trading Volume
Below 10d avg (569.6K)
488.8K
vs S&P 500 Today
Underperforming Market
-1.19%
Updated: October 2, 2026 at 20:02 UTC
STE Headlines
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$209.94 - $229.95Sell
- RSI (14)35.73Neutral
- Stochastic %K (14, 3, 3)48.00Neutral
- MACD Level (12, 26)-4.19Neutral
Peers & Related Assets
Get premium market insights delivered directly to your inbox.